期刊文献+

PET预测及评价肿瘤疗效的新进展 被引量:2

The new advance of prediction and evaluation of tumor therapeutic effects by PET
原文传递
导出
摘要 临床上评价及预测肿瘤疗效的手段很多,包括体格检查、普通影像学检查(X线摄片、CT、MRI等)和肿瘤标志物检测等,但这些方法均有很大的局限性,如主观性强、敏感性差等。PET可以早期准确地反映肿瘤相关生物特征,如血管生成、凋亡、乏氧和增殖等。因此,利用相应的可反映上述生物特征的显像剂行PET,可对肿瘤进行早期诊断、评价和预测肿瘤治疗的疗效,协助临床医生制定治疗方案。 There are many methods that evaluate and predicate the therapeutic effects of tumors, including physical examination, common imaging (X-ray, CT, MRI etc) and tumor marker etc. But these methods have many limits, for example: more subjective, less sensitivity etc. The relative biological features as angiogenesis, apoptosis, hypoxic and proliferation can be reflected by PET early and correctly. So, we can diagnose tumor, predict and evaluate its therapeutic effects by PET used the accorded tracers that reflect the above biological features. Helping clinical doctors to make therapeutic methods.
作者 闫瑾 林祥通
出处 《国际放射医学核医学杂志》 2006年第4期214-217,共4页 International Journal of Radiation Medicine and Nuclear Medicine
关键词 体层摄影术 发射型计算机 血管生成 细胞凋亡 低氧 增殖 Tomography, emission-computed Angiogenesis Apoptosis Hypoxia Proliferation
  • 相关文献

参考文献11

  • 1Folkman J.The role of angiogenesis in tumor growth.Semin Cancer Biol,1992,3(2):65-71.
  • 2Gasparini G,Toi M,Biganzoli E,et al.Thrombospondin-1 and -2 in node-negative breast cancer:correlation with angiogenic factors,p53,cathepsin D,hormone receptors and prognosis.Oncology,2001,60(1):72-80.
  • 3Fidler IJ.Angiogenesis and cancer metastasis.Cancer,2000,6(Suppl 2):S134-S141
  • 4Blankenberg FG,Naumovshi L,Tait JF,et al.Imaging cyclophosphamide-induced intramedullary apoptosis in rats using 99mTc-radiolabeled annexin V.J Nucl Med,2001,42(2):309-316.
  • 5Yang DJ,Azhdarinia A,Wu P,et al.In vivo and in vitro measurement of apoptosis in breast cancer cells using 99mTc-EC-annexin V.Cancer Biother Radiopharm,2001,16(1):73-83.
  • 6Bos R,Zhong H,Hanrahan GF,et al.Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis.J Natl Cancer Inst,2001,93(4):309-314.
  • 7Koumenis C,Alsrcon R,Hammond E,et al.Regulation of P53 byhypoxia dissociation of transcriptional repression and apoptosis from P53-dependent transactivition.Mol CellBiol,2001,21(4):.1297-1310.
  • 8Quinn CM,Wright NA.The clinical assessment of proliferation and growth in human tumours:evaluation of methods and applications as prognostic variables.J Pathol,1990,160(2):93-102.
  • 9Buck AK,Schirrmeister H,Hetzel M,et al.3-deoxy-3-[(18) F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules.Cancer Res,2002,62(12):3331-3334.
  • 10Weissleder R,Tunyg CH,Mahmood U,et al.In vivo imaging of tumors with protease-activated near-infrared fluorescent probes.Nt Biotechnol,1999,17(4):375-378.

同被引文献30

  • 1张雪峰.胃癌患者CT扫描前的准备技术[J].实用医技杂志,2007,14(19):2550-2551. 被引量:1
  • 2Kwee TC, Kwee RM, Verdonck LF, et al. Magnetic resonance imag- ing for the detection of bone marrow involvement in malignant lym- phoma[J]. Br JHaematol, 2008, 141 ( 1 ) : 60-68. DOI: 10. 1111/j. 1365-2141. 2008.07020. x.
  • 3Adams HJ, Kwee TC, Vermoolen MA, et al. Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospec- tive study in 116 patients and comparison with FDG-PET[J]. Eur Radiol, 2013, 23 (8) : 2271-2278. DOI: 10.1007/s00330-013-2835-9.
  • 4Daldrup-Link HE, Henning T, Link TM. MR imaging of therapy-in- duced changes of bone marrow[J]. Eur radiol, 2007, 17 (3): 743- 761. DOI: 10. 1007/s00330-006-0404-1.
  • 5Nakanishi K, Kobayashi M, Nakaguchi K, et al. Whole-body MRI for detecting metastatic bone tumor: diagnostic value of diffusion- weighted images[J]. Magn Reson Med Sci, 2007, 6(3) : 147-155. DOI: 10. 2463/mrms. 6. 147.
  • 6Takenaka D, Ohno Y, Matsumoto K, et al. Detection of bone metas- tases in non-small cell lung cancer patients : Comparison of whole- body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintig- raphy[J]. J Magn Reson Imaging, 2009, 30 (2): 298-308. DOI; 10. 1002/jmri. 21858.
  • 7Adams HJA, Kwee TC, Vermoolen MA, et al. Whole-body MRI for the detection of bone marrow involvement in lymphoma: prospec- tive study in 116 patients and comparison with FDG-PET[J]. Eur radiol, 2013, 23 (8): 2271-2278. DOI: 10.1007/s00330-013- 2835-9.
  • 8Kwee TC, Fijnheer R, Ludwig I, et al. Whole-body magnetic res- onaee imaging, including diffusion-weighted imaging, for diagnos- ing bone marrow involvement in malignant lymphoma[J]. Br J Haematol, 2010, 149(4): 628-630. DOI: 10. 1111/j. 1365-2141. 2010. 08093. x.
  • 9Brennan DD, Gleeson T, Coate LE, et al. A comparison of whole- body MRI and CT for the staging of lymphoma[J]. AIR Am J Roen- tqenol, 2005, 185(3): 711-716.
  • 10Kwee TC, Ludwig I, Uiterwaal CS, et al. ADC measurements in the evaluation of lymph nodes in patients with non-Hodgkin lymphom a: feasibility study[J]. Magn Res Mater Phy, Biol Med, 2011, 24 ( 1 ) : 1-8. DOI: 10. 1007/s10334-010-0226-7.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部